Cancer Family
Esophageal Neoplasm
CI-CAN-00000174Explore in graph →
Non-malignant555 active trials6 approved drugs12 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000174Explore in graph →
Clinical trials
2,208 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00061958 | Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal Junction | terminated | Phase 2 | 50 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00002930 | PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery | completed | Phase 2 / Phase 3 | 75 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 18, 2013 | clinicaltrials |
| NCT00003076 | Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus | completed | Phase 2 | 152 | University of Michigan Rogel Cancer CenterOTHER | 1 | Dec 19, 2012 | clinicaltrials |
| NCT00509561 | Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer | unknown | Phase 2 / Phase 3 | 259 | Wales Cancer Trials UnitOTHER | 1 | Dec 18, 2012 | clinicaltrials |
| NCT01688700 | Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma | unknown | Phase 2 | 60 | Zhejiang Cancer HospitalOTHER | 1 | Sep 20, 2012 | clinicaltrials |
| NCT00006081 | Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer | completed | Phase 2 | 37 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00012363 | S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus | completed | Phase 2 | 61 | SWOG Cancer Research NetworkNETWORK | 1 | Jun 14, 2012 | clinicaltrials |
| NCT00004897 | Combination Chemotherapy and Interferon Alfa Followed by Surgery and/or Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer | terminated | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 12, 2012 | clinicaltrials |
| NCT00445861 | Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery | completed | Phase 1 / Phase 2 | 27 | Swiss Cancer InstituteOTHER | 1 | Jun 11, 2012 | clinicaltrials |
| NCT00072033 | Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer | completed | Phase 2 | 66 | Swiss Cancer InstituteOTHER | 1 | Jun 5, 2012 | clinicaltrials |
| NCT00238407 | Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery | completed | Phase 2 | 21 | Swiss Cancer InstituteOTHER | 1 | Jun 5, 2012 | clinicaltrials |
| NCT00002984 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus | completed | Phase 1 / Phase 2 | 26 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 24, 2012 | clinicaltrials |
| NCT01605305 | Study on FOLFOX6 as First-line Therapy to Treat Recurrent or Metastatic Esophageal Cancer | completed | Phase 2 | 60 | Fudan UniversityOTHER | 0 | May 24, 2012 | clinicaltrials |
| NCT00520091 | Irinotecan, Cisplatin, and Radiation Therapy With or Without Celecoxib in Treating Patients With Stage II, Stage III, or Stage IV Esophageal Cancer | completed | Phase 2 | 14 | UNC Lineberger Comprehensive Cancer CenterOTHER | 0 | May 18, 2012 | clinicaltrials |
| NCT00017212 | DX-8951f in Treating Patients With Metastatic Stomach Cancer | completed | Phase 2 | — | Daiichi SankyoINDUSTRY | 2 | May 16, 2012 | clinicaltrials |
| NCT01262183 | Radio-chemotherapy With or Without Panitumumab (Vectibix®) in Irresectable Squamous Cell Carcinoma or Adenocarcinoma of the Oesophagus(PANORAMIC) | terminated | Phase 2 | 4 | Radboud University Medical CenterOTHER | 1 | May 11, 2012 | clinicaltrials |
| NCT00021047 | Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor | completed | Phase 1 / Phase 2 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00813072 | Study of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction Adenocarcinoma | completed | Phase 2 | 135 | PharmaEngineINDUSTRY | 6 | Mar 2, 2012 | clinicaltrials |
| NCT00821912 | TaxXel: Taxotere and Xeloda in Esophageal Cancer(TaxXel) | unknown | Phase 1 / Phase 2 | 93 | Karolinska University HospitalOTHER | 2 | Feb 28, 2012 | clinicaltrials |
| NCT00215995 | Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric Carcinomas | completed | Phase 2 | 21 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 2 | Jan 13, 2012 | clinicaltrials |
| NCT01486992 | mFOLFIRI Combine With Nimotuzumab Second Line Chemotherapy for Squamous-cell Carcinoma of the Esophagus | unknown | Phase 2 | 40 | Peking UniversityOTHER | 1 | Jan 12, 2012 | clinicaltrials |
| NCT00002935 | Photodynamic Therapy in Treating Patients With Early Esophageal Cancer | completed | Phase 2 | 30 | Roswell Park Cancer InstituteOTHER | 1 | Dec 23, 2011 | clinicaltrials |
| NCT00659113 | S-1, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIA, Stage III, or Stage IVA Esophageal Cancer That Can Be Removed by Surgery | unknown | Phase 2 | 32 | Yonsei UniversityOTHER | 1 | Dec 6, 2011 | clinicaltrials |
| NCT01349517 | Health-related Quality of Life of Patients With Esophageal Cancer After Surgery | unknown | Phase 2 | 400 | Fudan UniversityOTHER | 1 | Nov 11, 2011 | clinicaltrials |
| NCT00865982 | Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal Cancer(DCXAIOCHARITE) | unknown | Phase 2 | 50 | Charite University, Berlin, GermanyOTHER | 1 | Aug 5, 2011 | clinicaltrials |
| NCT01402180 | Chemoradiation With or Without Nimotuzumab in Treating Esophageal Cancer Patients Who Suffer With Recurrence in Regional Lymph Nodes After Esophagectomy(Nimotuzumab) | unknown | Phase 2 / Phase 3 | 128 | Fudan UniversityOTHER | 1 | Jul 26, 2011 | clinicaltrials |
| NCT00004233 | S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach | completed | Phase 2 | 65 | SWOG Cancer Research NetworkNETWORK | 1 | Jul 25, 2011 | clinicaltrials |
| NCT01391572 | A Trial Estimating The Optimal Radiation Volume Of Postsurgical Radiation For Patients With Esophageal Cancer | unknown | Phase 2 | 300 | Fudan UniversityOTHER | 1 | Jul 22, 2011 | clinicaltrials |
| NCT00002506 | Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer | completed | Phase 2 | — | Hoag Memorial Hospital PresbyterianOTHER | 1 | May 12, 2011 | clinicaltrials |
| NCT00051480 | Study of TNFerade™ Gene Therapy, Radiation, 5-FU and Cisplatin in Esophageal Cancer | completed | Phase 2 | — | GenVecINDUSTRY | 1 | May 12, 2011 | clinicaltrials |
| NCT00193141 | Chemotherapy With or Without Surgical Resection in Locally Advanced Esophageal Cancer | completed | Phase 2 | 200 | SCRI Development Innovations, LLCOTHER | 0 | May 3, 2011 | clinicaltrials |
| NCT01336049 | Nimotuzumab Plus Paclitaxel and Cisplatin as 1st Line Treatment for Esophageal Squamous Cell Cancer | unknown | Phase 2 | 70 | Peking UniversityOTHER | 1 | Apr 15, 2011 | clinicaltrials |
| NCT00578201 | FOLFOX-Cetuximab-radiotherapy for the Treatment of Esophageal Cancer(FOLFOX) | completed | Phase 2 | 80 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Mar 31, 2011 | clinicaltrials |
| NCT00003125 | Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors | completed | Phase 2 | 24 | Georgetown UniversityOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00060268 | Photodynamic Therapy Using HPPH in Treating Patients With Obstructive Esophageal Tumors | completed | Phase 1 / Phase 2 | 11 | Roswell Park Cancer InstituteOTHER | 1 | Mar 9, 2011 | clinicaltrials |
| NCT01144325 | Minimally Invasive Esophagectomy (MIE) in Prone Versus Left Decubitus Position | unknown | Phase 2 | 2 | Fudan UniversityOTHER | 1 | Mar 8, 2011 | clinicaltrials |
| NCT00815308 | Erbitux Combined With Chemo-radiotherapy in Esophageal Squamous Cell Carcinoma(EXCEL) | completed | Phase 2 | 55 | Shandong Cancer Hospital and InstituteOTHER | 1 | Feb 8, 2011 | clinicaltrials |
| NCT01291823 | Gefitinib Combined With Radiotherapy in Elderly Patients With Esophageal Cancer | unknown | Phase 2 | 70 | Zhejiang Cancer HospitalOTHER | 1 | Feb 8, 2011 | clinicaltrials |
| NCT01267578 | Peptide Vaccination in Treating Patients With Esophageal Cancer (STF-II) | unknown | Phase 2 | 60 | University of YamanashiOTHER | 1 | Dec 28, 2010 | clinicaltrials |
| NCT00669292 | PhaseⅠ/Ⅱ Study of URLC10-177 and TTK-567 Peptide Vaccine Combined With CpG7909 in Patients With Esophageal Cancer | unknown | Phase 1 / Phase 2 | 29 | Wakayama Medical UniversityOTHER | 1 | Sep 9, 2010 | clinicaltrials |
| NCT00915850 | Trial of Docetaxel, Cisplatin, Fluorouracil (5-FU) for Unresectable Advanced Esophageal Squamous Cell Carcinoma (ESCC) | unknown | Phase 1 / Phase 2 | 32 | Wakayama Medical UniversityOTHER | 1 | Sep 9, 2010 | clinicaltrials |
| NCT00453323 | Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancer | unknown | Phase 2 | 33 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 12, 2010 | clinicaltrials |
| NCT00209690 | Phase I/II Study of TPF as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer. | completed | Phase 1 / Phase 2 | 30 | Hokkaido Gastrointestinal Cancer Study GroupOTHER | 1 | May 26, 2010 | clinicaltrials |
| NCT00209716 | Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer. | completed | Phase 1 / Phase 2 | 30 | Hokkaido Gastrointestinal Cancer Study GroupOTHER | 1 | May 26, 2010 | clinicaltrials |
| NCT00230451 | Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma | completed | Phase 2 | — | University of Michigan Rogel Cancer CenterOTHER | 1 | Jan 15, 2010 | clinicaltrials |
| NCT01034332 | Paclitaxel/Cisplatin/Fluorouracil Followed by Paclitaxel/Cisplatin/Radiotherapy and Esophagectomy for Esophageal Cancer | unknown | Phase 2 | 58 | National Taiwan University HospitalOTHER | 1 | Dec 18, 2009 | clinicaltrials |
| NCT01034189 | Cetuximab/Paclitaxel/Cisplatin Concurrent Chemoradiotherapy Followed by Esophagectomy for Loco-regional Esophageal Cancer | unknown | Phase 2 | 62 | National Taiwan University HospitalOTHER | 1 | Dec 17, 2009 | clinicaltrials |
| NCT00220129 | Neoadjuvant Epirubicin, Cisplatin and Capecitabine (ECX) Followed by Definitive Chemoradiation With/Without Surgery for Squamous Cell Carcinoma of the Oesophagus | completed | Phase 2 | 16 | Royal Marsden NHS Foundation TrustOTHER | 1 | Dec 16, 2009 | clinicaltrials |
| NCT00066716 | Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus | completed | Phase 2 | 39 | Weill Medical College of Cornell UniversityOTHER | 1 | Dec 8, 2009 | clinicaltrials |
Data updated 22 days agoSource updated Jan 23, 2013source: clinicaltrials